Genmab A/S (GMAB)
34.35
+1.33
(+4.03%)
USD |
NASDAQ |
Aug 25, 16:00
34.35
0.00 (0.00%)
After-Hours: 19:59
Genmab Market Cap : 20.51B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 19.71B |
| August 21, 2026 | 19.97B |
| August 20, 2026 | 19.95B |
| August 19, 2026 | 20.36B |
| August 18, 2026 | 19.68B |
| August 17, 2026 | 19.61B |
| August 14, 2026 | 19.07B |
| August 13, 2026 | 18.71B |
| August 12, 2026 | 18.76B |
| August 11, 2026 | 18.42B |
| August 10, 2026 | 18.43B |
| August 07, 2026 | 18.66B |
| August 06, 2026 | 17.81B |
| August 05, 2026 | 17.47B |
| August 04, 2026 | 17.81B |
| August 03, 2026 | 17.60B |
| July 31, 2026 | 17.72B |
| July 30, 2026 | 17.58B |
| July 29, 2026 | 17.51B |
| July 28, 2026 | 17.80B |
| July 27, 2026 | 17.68B |
| July 24, 2026 | 17.72B |
| July 23, 2026 | 17.91B |
| July 22, 2026 | 17.71B |
| July 21, 2026 | 17.41B |
| Date | Value |
|---|---|
| July 20, 2026 | 17.13B |
| July 17, 2026 | 17.63B |
| July 16, 2026 | 17.79B |
| July 15, 2026 | 17.85B |
| July 14, 2026 | 17.64B |
| July 13, 2026 | 17.68B |
| July 10, 2026 | 17.80B |
| July 09, 2026 | 18.28B |
| July 08, 2026 | 18.13B |
| July 07, 2026 | 17.91B |
| July 06, 2026 | 17.19B |
| July 02, 2026 | 17.50B |
| July 01, 2026 | 16.97B |
| June 30, 2026 | 16.86B |
| June 29, 2026 | 15.97B |
| June 26, 2026 | 16.03B |
| June 25, 2026 | 16.05B |
| June 24, 2026 | 15.88B |
| June 23, 2026 | 15.92B |
| June 22, 2026 | 15.72B |
| June 18, 2026 | 15.51B |
| June 17, 2026 | 15.59B |
| June 16, 2026 | 15.19B |
| June 15, 2026 | 15.09B |
| June 12, 2026 | 15.40B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 469.70B |
| Ascendis Pharma A/S | 16.64B |
| Zealand Pharma A/S | 3.368B |
| Bavarian Nordic A/S | 2.517B |
| Evaxion AS | 28.27M |
Market Cap Related Metrics
| PE Ratio | 27.20 |
| PS Ratio | 5.304 |
| Price to Book Value | 3.443 |
| Price to Free Cash Flow | 25.19 |
| Price | 34.35 |
| Earnings Yield | 3.68% |
| Operating PE Ratio | 16.43 |
| Normalized PE Ratio | 22.29 |